[18F]FDG PET/CT versus [18F]FDG PET/MRI in staging of non-small cell lung cancer: a head-to-head comparative meta-analysis

PurposeThis meta-analysis aims to compare the diagnostic efficacy of [18F]FDG PET/CT and [18F]FDG PET/MRI in patients with non-small cell lung cancer (NSCLC).MethodsAn extensive literature search was conducted throughout the PubMed, Embase, and Web of Science databases for works accessible through S...

Full description

Saved in:
Bibliographic Details
Main Authors: Dandan Yu, Chaolin Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2024.1517805/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841543743564414976
author Dandan Yu
Chaolin Chen
author_facet Dandan Yu
Chaolin Chen
author_sort Dandan Yu
collection DOAJ
description PurposeThis meta-analysis aims to compare the diagnostic efficacy of [18F]FDG PET/CT and [18F]FDG PET/MRI in patients with non-small cell lung cancer (NSCLC).MethodsAn extensive literature search was conducted throughout the PubMed, Embase, and Web of Science databases for works accessible through September 2024. We included studies assessed the diagnostic efficacy of [18F]FDG PET/CT and [18F]FDG PET/MRI in NSCLC.ResultsThe meta-analysis includes six studies with a total of 437 patients. The sensitivity and specificity of [18F]FDG PET/CT and [18F]FDG PET/MRI for detecting lymph node metastasis were similar, at 0.82 (0.68–0.94) vs. 0.86 (0.70–0.97) and 0.88 (0.76–0.96) vs. 0.90 (0.85–0.94), respectively, with no significant differences (p = 0.70 for sensitivity, p = 0.75 for specificity). For distant metastasis, the sensitivity of [18F]FDG PET/CT and [18F]FDG PET/MRI was 0.86 (0.60–1.00) and 0.93 (0.63–1.00), and specificity was 0.89 (0.65–1.00) vs. 0.90 (0.64–1.00), respectively, also showing no significant differences (p = 0.66 for sensitivity, p = 0.97 for specificity).ConclusionOur meta-analysis shows that [18F]FDG PET/MRI has similar sensitivity and specificity to [18F]FDG PET/CT in identifying lymph node and distant metastases in patients with NSCLC. Additional larger sample prospective studies are needed to confirm these findings.Systematic review registrationhttps://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42023479817, CRD42023479817.
format Article
id doaj-art-2b29efcb59c741b88107d6cad3e7c154
institution Kabale University
issn 2296-858X
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj-art-2b29efcb59c741b88107d6cad3e7c1542025-01-13T06:10:18ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2025-01-011110.3389/fmed.2024.15178051517805[18F]FDG PET/CT versus [18F]FDG PET/MRI in staging of non-small cell lung cancer: a head-to-head comparative meta-analysisDandan YuChaolin ChenPurposeThis meta-analysis aims to compare the diagnostic efficacy of [18F]FDG PET/CT and [18F]FDG PET/MRI in patients with non-small cell lung cancer (NSCLC).MethodsAn extensive literature search was conducted throughout the PubMed, Embase, and Web of Science databases for works accessible through September 2024. We included studies assessed the diagnostic efficacy of [18F]FDG PET/CT and [18F]FDG PET/MRI in NSCLC.ResultsThe meta-analysis includes six studies with a total of 437 patients. The sensitivity and specificity of [18F]FDG PET/CT and [18F]FDG PET/MRI for detecting lymph node metastasis were similar, at 0.82 (0.68–0.94) vs. 0.86 (0.70–0.97) and 0.88 (0.76–0.96) vs. 0.90 (0.85–0.94), respectively, with no significant differences (p = 0.70 for sensitivity, p = 0.75 for specificity). For distant metastasis, the sensitivity of [18F]FDG PET/CT and [18F]FDG PET/MRI was 0.86 (0.60–1.00) and 0.93 (0.63–1.00), and specificity was 0.89 (0.65–1.00) vs. 0.90 (0.64–1.00), respectively, also showing no significant differences (p = 0.66 for sensitivity, p = 0.97 for specificity).ConclusionOur meta-analysis shows that [18F]FDG PET/MRI has similar sensitivity and specificity to [18F]FDG PET/CT in identifying lymph node and distant metastases in patients with NSCLC. Additional larger sample prospective studies are needed to confirm these findings.Systematic review registrationhttps://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42023479817, CRD42023479817.https://www.frontiersin.org/articles/10.3389/fmed.2024.1517805/full[18F]FDG PET/CT[18F]FDG PET/MRInon-small cell lung cancermeta-analaysisstaging
spellingShingle Dandan Yu
Chaolin Chen
[18F]FDG PET/CT versus [18F]FDG PET/MRI in staging of non-small cell lung cancer: a head-to-head comparative meta-analysis
Frontiers in Medicine
[18F]FDG PET/CT
[18F]FDG PET/MRI
non-small cell lung cancer
meta-analaysis
staging
title [18F]FDG PET/CT versus [18F]FDG PET/MRI in staging of non-small cell lung cancer: a head-to-head comparative meta-analysis
title_full [18F]FDG PET/CT versus [18F]FDG PET/MRI in staging of non-small cell lung cancer: a head-to-head comparative meta-analysis
title_fullStr [18F]FDG PET/CT versus [18F]FDG PET/MRI in staging of non-small cell lung cancer: a head-to-head comparative meta-analysis
title_full_unstemmed [18F]FDG PET/CT versus [18F]FDG PET/MRI in staging of non-small cell lung cancer: a head-to-head comparative meta-analysis
title_short [18F]FDG PET/CT versus [18F]FDG PET/MRI in staging of non-small cell lung cancer: a head-to-head comparative meta-analysis
title_sort 18f fdg pet ct versus 18f fdg pet mri in staging of non small cell lung cancer a head to head comparative meta analysis
topic [18F]FDG PET/CT
[18F]FDG PET/MRI
non-small cell lung cancer
meta-analaysis
staging
url https://www.frontiersin.org/articles/10.3389/fmed.2024.1517805/full
work_keys_str_mv AT dandanyu 18ffdgpetctversus18ffdgpetmriinstagingofnonsmallcelllungcanceraheadtoheadcomparativemetaanalysis
AT chaolinchen 18ffdgpetctversus18ffdgpetmriinstagingofnonsmallcelllungcanceraheadtoheadcomparativemetaanalysis